FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1499281000168106: Takhzyro (lanadelumab 300 mg / 2 mL) injection, 1 x 2 mL syringe (containered trade product pack)


Status: current, Defined. Date: 31-Oct 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4469901000168119 Takhzyro (lanadelumab 300 mg / 2 mL) injection, 1 x 2 mL syringe (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4469911000168116 Takhzyro 300 mg/2 mL injection, 2 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Takhzyro 300 mg/2 mL injection, 2 mL syringe Is a Takhzyro 300 mg/2 mL injection, 2 mL syringe true Inferred relationship Some
Takhzyro 300 mg/2 mL injection, 2 mL syringe Is a containered trade product pack true Inferred relationship Some
Takhzyro 300 mg/2 mL injection, 2 mL syringe has container type syringe true Inferred relationship Some
Takhzyro 300 mg/2 mL injection, 2 mL syringe has TP Takhzyro true Inferred relationship Some
Takhzyro 300 mg/2 mL injection, 2 mL syringe has TPUU Takhzyro 300 mg/2 mL injection, 2 mL syringe true Inferred relationship Some 90712427

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Black Triangle Scheme reference set

Containered trade product pack reference set

Back to Start